278 related articles for article (PubMed ID: 16799716)
1. Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect.
Lumniczky K; Sáfrány G
Pathol Oncol Res; 2006; 12(2):118-24. PubMed ID: 16799716
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis.
Sato T; Neschadim A; Nakagawa R; Yanagisawa T; Medin JA
Methods Mol Biol; 2015; 1317():55-67. PubMed ID: 26072401
[TBL] [Abstract][Full Text] [Related]
3. Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant Cells.
Neschadim A; Medin JA
Methods Mol Biol; 2019; 1895():149-163. PubMed ID: 30539536
[TBL] [Abstract][Full Text] [Related]
4. The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer.
Sato T; Neschadim A; Lavie A; Yanagisawa T; Medin JA
PLoS One; 2013; 8(10):e78711. PubMed ID: 24194950
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+.
Doloff JC; Su T; Waxman DJ
BMC Cancer; 2010 Sep; 10():487. PubMed ID: 20836875
[TBL] [Abstract][Full Text] [Related]
6. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy strategies to improve the effectiveness of cancer radiotherapy.
Freytag SO; Kim JH; Brown SL; Barton K; Lu M; Chung M
Expert Opin Biol Ther; 2004 Nov; 4(11):1757-70. PubMed ID: 15500404
[TBL] [Abstract][Full Text] [Related]
8. Suicide gene therapy in cancer: where do we stand now?
Duarte S; Carle G; Faneca H; de Lima MC; Pierrefite-Carle V
Cancer Lett; 2012 Nov; 324(2):160-70. PubMed ID: 22634584
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid enhances bystander effect of suicide gene therapy in the treatment of breast cancer.
Kong H; Liu X; Yang L; Qi K; Zhang H; Zhang J; Huang Z; Wang H
Oncol Rep; 2016 Mar; 35(3):1868-74. PubMed ID: 26717879
[TBL] [Abstract][Full Text] [Related]
10. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
11. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes.
Denning C; Pitts JD
Hum Gene Ther; 1997 Oct; 8(15):1825-35. PubMed ID: 9358032
[TBL] [Abstract][Full Text] [Related]
12. Introduction to the background, principles, and state of the art in suicide gene therapy.
Niculescu-Duvaz I; Springer CJ
Mol Biotechnol; 2005 May; 30(1):71-88. PubMed ID: 15805578
[TBL] [Abstract][Full Text] [Related]
13. Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.
Robson T; Worthington J; McKeown SR; Hirst DG
Technol Cancer Res Treat; 2005 Aug; 4(4):343-61. PubMed ID: 16029055
[TBL] [Abstract][Full Text] [Related]
14. Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Xiao J; Zhang G; Li B; Wu Y; Liu X; Tan Y; Du B
Oncotarget; 2017 Jan; 8(1):798-807. PubMed ID: 27903977
[TBL] [Abstract][Full Text] [Related]
15. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer.
Matono S; Tanaka T; Sueyoshi S; Yamana H; Fujita H; Shirouzu K
Int J Oncol; 2003 Nov; 23(5):1309-15. PubMed ID: 14532970
[TBL] [Abstract][Full Text] [Related]
16. Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics.
Cai J; Lin Y; Zhang H; Liang J; Tan Y; Cavenee WK; Yan G
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6812-6817. PubMed ID: 28607091
[TBL] [Abstract][Full Text] [Related]
17. Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors.
Amara I; Pramil E; Senamaud-Beaufort C; Devillers A; Macedo R; Lescaille G; Seguin J; Tartour E; Lemoine FM; Beaune P; de Waziers I
J Control Release; 2016 Oct; 239():82-91. PubMed ID: 27565211
[TBL] [Abstract][Full Text] [Related]
18. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
19. Gene therapeutic approaches for medullary thyroid carcinoma treatment.
Drosten M; Pützer BM
J Mol Med (Berl); 2003 Jul; 81(7):411-9. PubMed ID: 12811413
[TBL] [Abstract][Full Text] [Related]
20. [Radiation-induced bystander effect: the important part of ionizing radiation response. Potential clinical implications].
Wideł M; Przybyszewski W; Rzeszowska-Wolny J
Postepy Hig Med Dosw (Online); 2009 Aug; 63():377-88. PubMed ID: 19724078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
